Gfl-1 Antibody Blocking peptide
Gfl-1 Antibody Blocking peptide
Product Specifications
UniProt
Q21501
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the N-term region of human Gfl-1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1042111-01 0.02 mg (E-Coli)
Recombinant Shewanella baltica 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Sign In for Pricing
View Details MBS1042111-02 0.02 mg (Yeast)
Recombinant Shewanella baltica 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Sign In for Pricing
View Details MBS1042111-03 0.1 mg (E-Coli)
Recombinant Shewanella baltica 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Sign In for Pricing
View Details MBS1042111-04 0.1 mg (Yeast)
Recombinant Shewanella baltica 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Sign In for Pricing
View Details MBS1042111-05 0.02 mg (Baculovirus)
Recombinant Shewanella baltica 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Sign In for Pricing
View Details MBS1042111-06 0.02 mg (Mammalian-Cell)
Recombinant Shewanella baltica 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Sign In for Pricing
View Details